Vyne Therapeutics (United States)
- Research works
- 33 ▲ 227% vs 2018-21
- Citations
- 433 13.2 per fractional work
- Top-10% rate
- 19.2% all institutions 10.0%
- Open access
- 49% world 40%
- International
- 38% world 18%
Not ranked overall: Vyne Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Vyne Therapeutics (United States) work in?
In 2022-now, 58% of research at Vyne Therapeutics (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (6%). It does 1.9× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 12 fields, with their numbers
- Health Sciences1258.2%
- Medicine1256.4%
- Health Professions01.3%
- Nursing00.5%
- Life Sciences837.0%
- Physical Sciences13.1%
- Engineering02.0%
- Chemistry00.8%
- Computer Science00.3%
- Social Sciences01.7%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.3×. Every wedge is a field page.
All 12 fields, with their numbers
- Immunology and Microbiology6.30×1 works
- Biochemistry, Genetics and Molecular Biology4.71×5 works
- Pharmacology, Toxicology and Pharmaceutics3.74×0 works
- Medicine2.93×12 works
- Neuroscience2.58×1 works
- Nursing1.08×0 works
- Arts and Humanities0.55×0 works
- Chemistry0.50×0 works
- Health Professions0.50×0 works
- Engineering0.13×0 works
- Economics, Econometrics and Finance0.05×0 works
- Computer Science0.04×0 works
- Immunology and Microbiology 6.3×
- Biochemistry, Genetics and Molecular Biology 4.7×
- Pharmacology, Toxicology and Pharmaceutics 3.7×
- Medicine 2.9×
- Neuroscience 2.6×
- Nursing 1.1×
- Arts and Humanities 0.6×
- Chemistry 0.5×
- Health Professions 0.5×
- Engineering 0.1×
- Economics, Econometrics and Finance 0.1×
- Computer Science 0.0×
Which keywords describe research at Vyne Therapeutics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, CFTR, Cystic Fibrosis, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Glycosylation and Monoclonal Antibodies.
- Fc Receptors
- Cancer
- Nanoparticles
- Monoclonal Antibodies
- Chimeric Antigen Receptor
- Lymphoma
- CFTR
- Immunotherapy
- Cystic Fibrosis
- CAR T Cells
- Glycosylation
- Inhaler Devices
- Pulmonary Drug Delivery
- Cancer Therapy
- Therapeutic Antibodies
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 15 words, with their numbers
- Immunotherapy2▲ 15×4 topics
- CFTR2▲ 264×1 topic
- Cystic Fibrosis2▲ 110×1 topic
- Lymphoma2▲ 46×2 topics
- CAR T Cells2▲ 98×1 topic
- Chimeric Antigen Receptor2▲ 98×1 topic
- Glycosylation1▲ 58×2 topics
- Monoclonal Antibodies1▲ 67×2 topics
- Inhaler Devices1▲ 199×1 topic
- Nanoparticles1▲ 4.2×2 topics
- Pulmonary Drug Delivery1▲ 199×1 topic
- Cancer1▲ 3.7×7 topics
- Cancer Therapy1▲ 8.4×3 topics
- Fc Receptors1▲ 87×1 topic
- Therapeutic Antibodies1▲ 68×1 topic
Which research topics does Vyne Therapeutics (United States) publish most on?
By volume in 2022-now: Cystic Fibrosis Research Advances, CAR-T cell therapy research, Inhalation and Respiratory Drug Delivery and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 2 works
- 2 CAR-T cell therapy research Oncology 2 works
- 3 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 5 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 1 works
- 6 Protein Degradation and Inhibitors Molecular Biology 1 works
- 7 Biochemical and Structural Characterization Molecular Biology 1 works
- 8 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 9 Respiratory viral infections research Epidemiology 1 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Vyne Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 227% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Vyne Therapeutics (United States) as a percentage of every work published that year, 0.000077% in 2024.
Fractional works of Vyne Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Menlo Park
- SRI International
- Meta (United States)
- Exponent (United States)
- Pacific Biosciences (United States)
- ATUM (United States)
- Personalis (United States)
- Geron (United States)
- Alpha Omega Alpha Medical Honor Society
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Vyne Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.